Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) EBT (2016 - 2025)

Historic EBT for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $67.5 million.

  • Healthequity's EBT rose 98607.27% to $67.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $246.5 million, marking a year-over-year increase of 11288.02%. This contributed to the annual value of $116.0 million for FY2025, which is 5462.95% up from last year.
  • Per Healthequity's latest filing, its EBT stood at $67.5 million for Q4 2025, which was up 98607.27% from $78.0 million recorded in Q3 2025.
  • Over the past 5 years, Healthequity's EBT peaked at $78.0 million during Q3 2025, and registered a low of -$43.8 million during Q1 2022.
  • Over the past 5 years, Healthequity's median EBT value was $8.1 million (recorded in 2023), while the average stood at $15.1 million.
  • As far as peak fluctuations go, Healthequity's EBT tumbled by 316117.73% in 2022, and later soared by 37136250.0% in 2024.
  • Quarter analysis of 5 years shows Healthequity's EBT stood at -$9.1 million in 2021, then soared by 32.27% to -$6.2 million in 2022, then soared by 441.21% to $21.1 million in 2023, then crashed by 70.51% to $6.2 million in 2024, then surged by 986.07% to $67.5 million in 2025.
  • Its last three reported values are $67.5 million in Q4 2025, $78.0 million for Q3 2025, and $71.0 million during Q2 2025.